In addition, activation of SirT3 accelerates glucose metabolism via upregulation of PPARα [47], and SirT3-induced metabolic reprogramming has been shown to sustain cardiomyocyte function in a mouse model of heart failure [48]. Here, PPARA is linked to heart failure.